Robert H. Bates
Affiliations: | 2009 | Scripps Research Institute, La Jolla, La Jolla, CA, United States |
Google:
"Robert Bates"Mean distance: 7.84
Parents
Sign in to add mentor| William R. Roush | grad student | 2009 | Scripps Institute | |
| (Studies toward the total synthesis of amphidinolide C.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wilson C, Ray P, Zuccotto F, et al. (2021) Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target. Journal of Medicinal Chemistry |
| Balabon O, Pitta E, Rogacki MK, et al. (2020) Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors. Journal of Medicinal Chemistry |
| Cunningham F, Esquivias J, Fernández-Menéndez R, et al. (2020) Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization around a Genotoxic Metabolite. Acs Infectious Diseases |
| Poce G, Consalvi S, Venditti G, et al. (2019) Novel Pyrazole-Containing Compounds Active against . Acs Medicinal Chemistry Letters. 10: 1423-1429 |
| Rogacki MK, Pitta E, Balabon OB, et al. (2018) Identification and profiling of hydantoins - a novel class of potent antimycobacterial DprE1 inhibitors. Journal of Medicinal Chemistry |
| Fang C, Lee KK, Nietupski R, et al. (2018) Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors. Bioorganic & Medicinal Chemistry Letters |
| Richter A, Rudolph I, Möllmann U, et al. (2018) Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1. Scientific Reports. 8: 13473 |
| Prati F, Zuccotto F, Fletcher D, et al. (2018) Screening of a novel fragment library with functional complexity against Mycobacterium tuberculosis InhA. Chemmedchem |
| Poce G, Cocozza M, Alfonso S, et al. (2017) In vivo potent BM635 analogue with improved drug-like properties. European Journal of Medicinal Chemistry. 145: 539-550 |
| Machutta CA, Kollmann CS, Lind KE, et al. (2017) Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening. Nature Communications. 8: 16081 |